Abstract
In the development process of human pharmaceutical therapeutics, toxicology studies play an important role in establishing the safety profiles of compounds. A battery of in vitro and in vivo studies is conducted for this purpose. Animals commonly used in toxicology studies include rats, mice, dogs, and monkeys. Interpretation of toxicological studies often hinges on the actual exposure of the animals to the compound. The amount of the compound administered to an animal is not necessarily the same as the amount reaching the intended site of action. Knowledge of the systemic exposure of an animal to a compound gives us an indication of the amount of the compound that is responsible for the actions. The exposure information allows an assessment of the linear correlation with pharmacodynamic measurements. For example, if heart rate was the biological/toxicological endpoint of interest, then increases in the area under the plasma concentration-time curve (AUC) could be compared to increases in the heart rate to determine a correlation between the pharmacodynamic and pharmacokinetic measurements. If there is a good correlation, then the area under the plasma concentration-time curve can be used to predict heart rate changes. If there is not a good correlation, this would suggest that the compound may be sequestered in tissues and, thus, have biological activity beyond the exposure measured in the blood. Alternatively, it could indicate that the dose range used was not wide enough to cause a range of responses in the heart rate.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Bailer, A.J. (1998). Testing for the equality of area under the curves when using destructive measurement techniques. Journal of Pharmacokinetics and Biopharmaceutics 16, 303–309.
Bailer, A.J. and Ruberg, S.J. (1996). Randomization tests for assessing the equality of area under curves for studies using destructive sampling. Journal of Applied Toxicology 16, 391–395.
Beatty, D.A. and Peigorsch, W.W. (1997). Optimal statistical design for toxicokinetic studies. Statistical Methods in Medical Research 6, 359–376.
Bullingham, R., Monroe, S., Nicholls, A. and Hale, M. (1996). Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration. Journal of Clinical Pharmacology 36, 315–324.
International Conference on Harmonization (1995). Guideline on the assessment of systemic exposure in toxicity studies. Federal Register 60, 112641 1268.
Pai, S.M., Feltner, S.H, Hjian, G., Cayen, M.N., and Batra, V.K. (1996). Characterization of AUCs from sparsely sampled populations in toxicology studies. Pharmaceutical Research 13, 1283–1290.
Piegorsch, W.W. and Bailer, A.J. (1989). Optimal design allocations for estimating area under curves for studies employing destructive sampling. Journal of Pharmacokinetics and Biopharmaceutics 17, 493–507.
Rae, S., Raboud, J.M., Conway, B., Reiss, P., Vella, S., Cooper, D., Lange, J., Harris, M., Wainberg, M.A., Robinson, P., Myers, M., Hall, D., and Montaner, J.S.G. (1998). Estimates of the virological benefit of antiretroviral therapy are both assay-and analysis-dependent. AIDS. 12, 2185–2192.
Vandenhende, F., Dewe, W., and Hoffman, W.P. (1998). A likelihood-based analysis of drug exposure in toxicokinetic studies. The XIXth International Biometric Conference. IBC98, p. 297.
Yeh, C. (1990). Estimation and significance tests of area under the curve derived from incomplete blood sampling. American Statistical Association, 1990 Proceedings of the Biopharmaceutical Section, pp. 74–81.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hoffman, W.P., Heathman, M.A., Chou, J.Z., Allen, D.L. (2001). Analysis of Toxicokinetic and Pharmacokinetic Data from Animal Studies. In: Millard, S.P., Krause, A. (eds) Applied Statistics in the Pharmaceutical Industry. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-3466-9_4
Download citation
DOI: https://doi.org/10.1007/978-1-4757-3466-9_4
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-3166-5
Online ISBN: 978-1-4757-3466-9
eBook Packages: Springer Book Archive